These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34070254)

  • 61. Inhibition of visfatin by FK866 mitigates pathogenesis of cystic ovary in letrozole-induced hyperandrogenised mice.
    Annie L; Gurusubramanian G; Roy VK
    Life Sci; 2021 Jul; 276():119409. PubMed ID: 33781825
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
    Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
    Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Use of Optical Redox Imaging to Quantify Alveolar Macrophage Redox State in Infants: Proof of Concept Experiments in a Murine Model and Human Tracheal Aspirates Samples.
    Xu HN; Gonzalves D; Hoffman JH; Baur JA; Li LZ; Jensen EA
    Antioxidants (Basel); 2024 Apr; 13(5):. PubMed ID: 38790651
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High expression of NAMPT in adult T-cell leukemia/lymphoma and anti-tumor activity of a NAMPT inhibitor.
    Kozako T; Aikawa A; Ohsugi T; Uchida YI; Kato N; Sato K; Ishitsuka K; Yoshimitsu M; Honda SI
    Eur J Pharmacol; 2019 Dec; 865():172738. PubMed ID: 31614144
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nampt/PBEF/visfatin and cancer.
    Bi TQ; Che XM
    Cancer Biol Ther; 2010 Jul; 10(2):119-25. PubMed ID: 20647743
    [TBL] [Abstract][Full Text] [Related]  

  • 66. EIF2A-dependent translational arrest protects leukemia cells from the energetic stress induced by NAMPT inhibition.
    Zucal C; D'Agostino VG; Casini A; Mantelli B; Thongon N; Soncini D; Caffa I; Cea M; Ballestrero A; Quattrone A; Indraccolo S; Nencioni A; Provenzani A
    BMC Cancer; 2015 Nov; 15():855. PubMed ID: 26542945
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nicotinamide phosphoribosyltransferase postpones rat bone marrow mesenchymal stem cell senescence by mediating NAD
    Pi C; Yang Y; Sun Y; Wang H; Sun H; Ma M; Lin L; Shi Y; Li Y; Li Y; He X
    Aging (Albany NY); 2019 Jun; 11(11):3505-3522. PubMed ID: 31175267
    [No Abstract]   [Full Text] [Related]  

  • 68. Inhibition of nicotinamide phosphoribosyltransferase and depletion of nicotinamide adenine dinucleotide contribute to arsenic trioxide suppression of oral squamous cell carcinoma.
    Wang XY; Wang JZ; Gao L; Zhang FY; Wang Q; Liu KJ; Xiang B
    Toxicol Appl Pharmacol; 2017 Sep; 331():54-61. PubMed ID: 28501332
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications.
    Tan B; Young DA; Lu ZH; Wang T; Meier TI; Shepard RL; Roth K; Zhai Y; Huss K; Kuo MS; Gillig J; Parthasarathy S; Burkholder TP; Smith MC; Geeganage S; Zhao G
    J Biol Chem; 2013 Feb; 288(5):3500-11. PubMed ID: 23239881
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Up-regulation of nicotinamide phosphoribosyltransferase and increase of NAD+ levels by glucose restriction extend replicative lifespan of human fibroblast Hs68 cells.
    Yang NC; Song TY; Chang YZ; Chen MY; Hu ML
    Biogerontology; 2015 Feb; 16(1):31-42. PubMed ID: 25146190
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool.
    Pittelli M; Formentini L; Faraco G; Lapucci A; Rapizzi E; Cialdai F; Romano G; Moneti G; Moroni F; Chiarugi A
    J Biol Chem; 2010 Oct; 285(44):34106-14. PubMed ID: 20724478
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MC-PPEA as a new and more potent inhibitor of CLP-induced sepsis and pulmonary inflammation than FK866.
    Huang P; Lee MW; Sadrerafi K; Heruth DP; Zhang LQ; Maulik D; Ye SQ
    Drug Des Devel Ther; 2017; 11():629-641. PubMed ID: 28424540
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Proinflammatory actions of visfatin/nicotinamide phosphoribosyltransferase (Nampt) involve regulation of insulin signaling pathway and Nampt enzymatic activity.
    Jacques C; Holzenberger M; Mladenovic Z; Salvat C; Pecchi E; Berenbaum F; Gosset M
    J Biol Chem; 2012 Apr; 287(18):15100-8. PubMed ID: 22399297
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A preclinical study on the rescue of normal tissue by nicotinic acid in high-dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor.
    Olesen UH; Thougaard AV; Jensen PB; Sehested M
    Mol Cancer Ther; 2010 Jun; 9(6):1609-17. PubMed ID: 20515945
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Relationship between Optical Redox Status and Reactive Oxygen Species in Cancer Cells.
    Podsednik A; Jacob A; Li LZ; Xu HN
    React Oxyg Species (Apex); 2020 Mar; 9(26):95-108. PubMed ID: 32066994
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Divergent metabolic responses dictate vulnerability to NAMPT inhibition in ovarian cancer.
    Kudo K; Nomura M; Sakamoto Y; Ito S; Morita M; Kawai M; Yamashita Y; Ito K; Yamada H; Shima H; Yaegashi N; Tanuma N
    FEBS Lett; 2020 May; 594(9):1379-1388. PubMed ID: 31950503
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibition of NAMPT sensitizes MOLT4 leukemia cells for etoposide treatment through the SIRT2-p53 pathway.
    Grohmann T; Penke M; Petzold-Quinque S; Schuster S; Richter S; Kiess W; Garten A
    Leuk Res; 2018 Jun; 69():39-46. PubMed ID: 29653431
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Endogenous NAMPT dampens chemokine expression and apoptotic responses in stressed tubular cells.
    Benito-Martin A; Ucero AC; Izquierdo MC; Santamaria B; Picatoste B; Carrasco S; Lorenzo O; Ruiz-Ortega M; Egido J; Ortiz A
    Biochim Biophys Acta; 2014 Feb; 1842(2):293-303. PubMed ID: 24287278
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibition of nicotinamide phosphoribosyltransferase modifies LPS-induced inflammatory responses of human monocytes.
    Schilling E; Wehrhahn J; Klein C; Raulien N; Ceglarek U; Hauschildt S
    Innate Immun; 2012 Jun; 18(3):518-30. PubMed ID: 21975728
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nampt promotes osteogenic differentiation and lipopolysaccharide-induced interleukin-6 secretion in osteoblastic MC3T3-E1 cells.
    He S; Zhang H; Lu Y; Zhang Z; Zhang X; Zhou N; Hu Z
    Aging (Albany NY); 2021 Feb; 13(4):5150-5163. PubMed ID: 33535169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.